The trade of quarterbacks with the Browns seems like a win-win as the Eagles have Tanner McKee on the roster and are managing ...
Trading away Gardner-Johnson might not be a popular move to make at present, but it does give Howie Roseman some financial ...
More licensees are packaging tech costs into their fees, but they may now need to re-consider whether tech software is ...
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
Aaron Rodgers has yet to make a decision on his next team, but it appears he has two possible landing spots in the New York ...
Looming economic fears have some in the ArkLaTex concerned and feeling like everything is getting more expensive.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...
From strategic hydration to sleep habits, discover nine proven methods to revitalize your aging metabolism and maintain a ...
The Army wants to cut down on redundant and excess equipment that its soldiers carry into battle, hoping that none carry more ...
Electric vehicles (EVs) have had a weird year so far. Thanks to Elon Musk, Tesla fell from grace. As the brand synonymous ...
Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma (ZLDPF), the companies announced Wednesday. The deal would give ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results